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ABSTRACT
The mitochondrial transcription factor A (mtTFA)
is central to assembly and initiation of the mito-
chondrial transcription complex. Human mtTFA
(h-mtTFA) is a dual high mobility group box
(HMGB) protein that binds site-specifically to the
mitochondrial genome and demarcates the pro-
moters for recruitment of h-mtTFB1, h-mtTFB2 and
the mitochondrial RNA polymerase. The stoichio-
metry of h-mtTFA was found to be a monomer in
the absence of DNA, whereas it formed a dimer in
the complex with the light strand promoter (LSP)
DNA. Each of the HMG boxes and the C-terminal
tail were evaluated for their ability to bind to the
LSP DNA. Removal of the C-terminal tail only slightly
decreased nonsequence specific DNA binding,
and box A, but not box B, was capable of binding
to the LSP DNA. The X-ray crystal structure of
h-mtTFA box B, at 1.35A ˚ resolution, revealed the
features of a noncanonical HMG box. Interactions
of box B with other regions of h-mtTFA were
observed. Together, these results provide an expla-
nation for the unusual DNA-binding properties
of box B and suggest possible roles for this
domain in transcription complex assembly.
INTRODUCTION
The mitochondrion is unique among the organelles in
eukaryotes because it contains its own genome indepen-
dent of the nucleus and replicates this genome separately
from the cell cycle (1). The human mitochondrial genome
(mtDNA) is a circular double-stranded DNA molecule of
16569 base pairs in length (2,3), which encodes 13 protein
components of the oxidative phosphorylation pathway,
22 tRNAs and two rRNAs (2,4). The oxidative environ-
ment of the mitochondria and lack of an eﬃcient DNA
repair mechanism leave the mitochondrial genome highly
susceptible to mutations, and such mutations have been
implicated in a variety of disease processes (5,6).
Transcription of the mitochondrial genome initiates
from three promoters: the light strand promoter (LSP)
or two heavy strand promoters (HSP1 and HSP2) that
are found in the 1.1kb displacement loop region of the
mtDNA (4,7). This generates long primary polycistronic
transcripts that contain no introns. Transcription from the
HSP1 produces the two rRNA species, whereas the tRNA
and mRNA species are generated from transcripts initiat-
ing at the HSP2 and LSP (8). In contrast to transcription
in the nucleus, only a small number of nuclear encoded
protein components are required for mitochondrial tran-
scription. These factors include the mitochondrial tran-
scription factor A (h-mtTFA also known as TFAM),
mitochondrial transcription factor B1 and B2
(h-mtTFB1 and h-mtTFB2), as well as the bacterioph-
age-related mitochondrial RNA polymerase (4,9).
Initiation of mitochondrial transcription requires spec-
iﬁcation of the mitochondrial promoter by h-mtTFA and
subsequent recruitment of additional components of the
transcription machinery. The ﬁrst transcription factor of
the mitochondrial transcription system to be discovered
was h-mtTFA and DNaseI footprinting identiﬁed its bind-
ing sites in the LSP (10,11). The later back-to-back dis-
covery and functional analyses of the factors h-mtTFB1
and h-mtTFB2 revealed that both proteins have roles
in transcription activation (12,13). Interestingly, both
h-mtTFB1 and h-mtTFB2 also have RNA methyltransfer-
ase activity (12–16). This led to the proposal that
h-mtTFB1 and h-mtTFB2 have dual functions in the
mitochondria, acting both as transcription factors and as
methyltransferases that may aid in coupling transcription
to translation in mitochondria (12,13,15,17). h-mtTFB1
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residue tail of h-mtTFA and the mitochondrial RNA
polymerase, and h-mtTFB1 has been shown to activate
transcription independently of its methyltransferase activ-
ity (15).
mtTFA is a member of the high mobility group
(HMGB) superfamily of DNA binding proteins deﬁned
by the HMG DNA binding domain (known as the
HMG box). The HMG box is an L-shaped three-helix
domain that binds to DNA in the minor groove and dra-
matically bends and unwinds DNA with the help of DNA
intercalating residues. One group of HMGB proteins is
associated with the maintenance and architecture of
DNA in nuclear chromatin through nonsequence-speciﬁc
DNA binding, and another is involved in the transcrip-
tional activation of speciﬁc genes through site-speciﬁc
DNA binding in gene promoter regions (18–20). The
sequence-speciﬁc HMGB proteins typically contain one
HMG domain, whereas the nonsequence-speciﬁc HMGB
proteins usually have two HMG domains. mtTFA is
unique in that it is site-speciﬁc, but contains tandem
HMG-box DNA-binding domains. A 27 amino acid resi-
due linker connects the HMG boxes, which are followed
by a 25 residue carboxyl-terminal tail that is rich in basic
amino acid residues. The C-terminal tail is essential for
speciﬁc DNA recognition as well as transcription initia-
tion and activation (21,22). h-mtTFA activates transcrip-
tion by binding upstream of transcriptional start sites and
induces conformational changes in the DNA such as
bending and DNA unwinding (11). In contrast to other
HMGB proteins, there is evidence that mtTFA can oligo-
merize. A dimer of h-mtTFA is needed to drive mtDNA
into a compacted nucleoid structure (23), and in Xenopus
laevis mtTFA (xl-mtTFA) tetramer formation is necessary
for bidirectional transcriptional activation (24).
In addition to its role as a transcription factor, mtTFA
has also been implicated as a primary structural factor in
forming the architecture of the mitochondrial genome.
The ability of mtTFA to inﬂuence mtDNA copy number
is largely independent of its role in transcription
(17,25,26). h-mtTFA has been shown to bind to DNA in
a nonsequence-speciﬁc fashion, as indicated by DNA
binding without a detectable DNaseI footprint (26,27).
xl-mtTFA was identiﬁed as one of the main protein com-
ponents in the nucleoprotein complex (28), indicating a
role in xl-mtDNA packaging. Therefore, mtTFA shares
a number of features with both the transcription factor-
type and the chromosomal-type HMG proteins.
Several mechanisms of how h-mtTFA may initiate
assembly of the transcription complex on mitochondrial
DNA have been proposed (4). However, the precise molec-
ular mechanism of assembly remains unclear. We investi-
gated the contribution of the HMG domains of h-mtTFA
to mitochondrial DNA binding to obtain a better under-
standing how h-mtTFA assembles on the mitochondrial
promoter. We ﬁrst determined the stoichiometry of
h-mtTFA in the presence and absence of promoter DNA
using a variety of complementary biophysical methods.
Next, a closer examination of the DNA binding propensity
of the individual domains of h-mtTFA suggested interest-
ing functional diﬀerences, and the crystal structure
at1.35A ˚ resolutionofboxBofh-mtTFAprovidedinsights
into these observed functional diﬀerences.
MATERIALS AND METHODS
Protein expression and purification
The plasmids for expression of full-length and deletion
constructs of h-mtTFA were created using Gateway
Cloning Technology (Invitrogen) as described in the
Supplementary Methods section. The h-mtTFA sequences
with an N-terminal PreScission protease cleavage site were
inserted into destination vectors that contained either
an N-terminal His6 (pDEST527) or N-terminal GST
(pDEST15) tag for protein expression in Escherichia coli
strain BL21(DE3)+Codon (Stratagene). The constructs
were veriﬁed by DNA sequencing.
The proteins were overexpressed in the E. coli strain
BL21(DE3)+codon in LB supplemented with 100mg/ml
ampicillin and 7mg/ml chloramphenical. A 1l culture was
inoculated from a glycerol stock and allowed to grow for
 16h at 378C without the addition of IPTG, which
allowed accumulation of protein due to leaky expression.
The cell pellet was resuspended in 20mM Tris-HCl pH
8.0, 1M NaCl, 1mM EDTA, 10% glycerol, protease
inhibitors (Roche), and 50mg of lysozyme prior to lysis
by sonication. After DNaseI treatment and centrifugation
(28435g), the cleared lysate was incubated with
Glutathione Sepharose (GE Healthcare) or Ni
2+-NTA
(Qiagen) resin. The resins were washed with 1 L of lysis
buﬀer followed by an additional wash with 1l of cleavage
buﬀer (20mM Tris–HCl pH 8.0, 150mM NaCl, 1mM
EDTA and 1mM DTT). The proteins were either cleaved
from the resin with PreScission Protease or eluted from
the resin with glutathione, to give the intact GST-fusion
proteins. The proteins were then dialyzed (50mM
HEPES–Na pH 7.0, 50mM NaCl, 1mM EDTA and
1mM DTT) and further puriﬁed using cation exchange
chromatography (Source S, GE Healthcare) and size-
exclusion chromatography (Superdex 200, GE
Healthcare). For the His6-tagged proteins, EDTA was
omitted from buﬀers, and the proteins were eluted from
the Ni
2+-NTA resin using imidazole.
Size-exclusion chromatography of h-mtTFA proteins
A 16/60 Superdex
TM 200 prep grade gel ﬁltration column
(GE Healthcare) was equilibrated in running buﬀer
(50mM HEPES–Na pH 7, 150mM NaCl, 1mM EDTA,
and 1mM DTT) at a ﬂow rate of 1ml/min. A calibration
curve was prepared using blue dextran (2000kDa), amy-
lase (158kDa), bovine serum albumin (67kDa), ovalbu-
min (43kDa), chymotrypsinogen A (25kDa) and RNase
A (13.7kDa) (GE Healthcare). The elution of these
markers was monitored by UV absorption at 280nm,
and the elution volume for each protein was measured
from the start of the sample application to the apex of
the elution peak. The logarithm of molecular weight was
plotted against Kav that was calculated for each protein as
follows: Kav=Ve–Vo/Vt – Vo, where Ve=elution volume
for the protein; Vo=column void volume=elution
volume of blue dextran 2000; Vt=total column volume.
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a volume of 2ml at between 3 and 10mg/ml using 5000
MWCO Vivaspin 20 centrifugal ﬁlter devices (Sartorius)
before loading onto the column.
Analytical ultracentrifugation
Sedimentation velocity ultracentrifugation experiments
were performed with a Beckman Optical XL-A analytical
ultracentrifuge at 258C in 50mM HEPES–Na pH 7.0,
150mM NaCl, 1mM EDTA and 1mM DTT with a 60
Ti rotor at 50000r.p.m. h-mtTFA was eluted from the gel
ﬁltration column and loaded into a Epon charcoal-ﬁlled
two sector center piece, and the running buﬀer was used
for the reference chamber. Samples were detected by
UV absorbance at 280nm. Sedimentation coeﬃcients
were corrected using SEDNTERP (29), which gave
Vbar=0.7365 and rho=1.00461. The experimental data
were analyzed with the program SEDFIT (30).
Electrophoretic mobility shiftassays
Stoichiometric and quantitative electrophoretic mobility
shift assays (EMSA) were used with the following linear
duplex DNA fragment: 50-GTGTTAGTTGGGGGGTG
ACTGTTAAAAGTG-30. For competition experiments
either the unlabeled 30bp fragment of the LSP or a
scrambled nonspeciﬁc 30bp fragment 50-ACTACTAAC
AGACCGCAACCTAAACACAAC-30 was utilized. The
32P end-labeled DNA was prepared as described pre-
viously (31). The labeled DNA was then annealed with
an excess of the complimentary strand of DNA and sepa-
rated from any remaining ssDNA by gel puriﬁcation.
Protein dilutions of h-mtTFA were made in 50mM
HEPES–Na pH 7.5, 150mM KCl, 1mM EDTA, 10%
glycerol and 1mM DTT to give a ﬁnal concentration
range of 0.5nM to 100mM. Each 10ml reaction mixture
included 2mg/ml bovine serum albumin, 1mlo f1 0   bind-
ing buﬀer (500mM HEPES–Na pH 7.5, 500mM KCl,
20mM MgCl2), 1ml of the protein dilution, and <1nM
radiolabeled DNA. The reactions were allowed to incu-
bate at 228C for 30min prior to loading on a pre-run 6%
native polyacrylamide gel (30:1, acrylamide: bis-acryla-
mide in 0.33  TBE). After electrophoresis, the gel was
dried and exposed to a phosphorimaging screen overnight.
A Molecular Dynamics phosphorimaging system was used
to digitize the gel images, and ImageQuant software
(Molecular Dynamics, Inc.) was used to integrate band
intensities corresponding to free and bound DNA at
each protein concentration. The fraction of DNA bound
was calculated and plotted for each protein concentration
using Kaleidagraph (Synergy software). The resulting
binding curves were ﬁt to a single-site binding isotherm
Y=([P]/Kd)/(1+[P]/Kd), where [P] is the total protein
concentration, and Y is the fraction bound, under condi-
tions where the DNA concentration is at least 10-fold
lower than the expected Kd. The equilibrium dissociation
constant (Kd) was obtained as a result of the curve ﬁt of
the mean of at least three independent experiments.
For unlabeled DNA duplexes equal amounts of the two
strands were resuspended in 50mM Tris–HCL (pH 7.4),
1mM EDTA, annealed and further puriﬁed using a
DEAE anion exchange column (Tosahaas) with an
increasing salt gradient in 50mM Tris–HCL (pH 7.4),
1mM EDTA. Protein dilutions of mtTFA were made in
50mM HEPES–Na (pH 7.5), 150mM NaCl, 1mM
EDTA, 10% glycerol and 1mM DTT to give a ﬁnal con-
centration of 10mM. Each 10ml reaction mixture included
2mg/ml BSA, 1mlo f1 0   binding buﬀer [200mM HEPES-
Na (pH 7.5), 500mM KCl, 20mM MgCl2], 0.5–2ml of the
protein dilution, and 1-3mM DNA. The reactions were
allowed to incubate at 258C prior to loading on a pre-
run 8% native polyacrylamide gel (30:1, acrylamide:
bis-acrylamide in 0.33  TBE). The samples were electro-
phoresed for 30min at 145V. The gels were then incu-
bated with Sybr Green (Invitrogen) for >20min and a
Molecular Dynamics phosphorimaging system was used
to digitize the gel images, and ImageQuant software
(Molecular Dynamics, Inc.) was used for visualization.
Crystallization and structure determination
h-mtTFA box B (mtTFA
110-179) was crystallized at 188C
from a 1:1 ratio of protein to well solution (0.1M acetate-
Na pH 5.0, 0.1M CdCl2 and 21% PEG 4000) in a hanging
drop format, after optimization from initial crystals found
in commercial crystallization screens (Hampton 1 and 2;
Hampton Research). The crystals were cryoprotected with
glycerol and PEG 4000 and ﬂash frozen prior to data
collection. The protein crystallized in the space group
C2221 with a=30.28A ˚ ; b=99.35A ˚ ; c=51.90A ˚ , with
one molecule per asymmetric unit.
Data were collected at the Molecular Biology
Consortium at the Advanced Light Source, Lawrence
Berkeley National Laboratory (Beamline 4.2.2) and were
indexed, integrated, and scaled using d trek (Rigaku)
(Table 2). Anomalous data were collected at 0.98A ˚ , due
to the presence of bound CdCl2 in the crystals (Table 2).
Single wavelength anomalous diﬀraction (SAD) methods
were used to obtain experimental phases for the structure
of h-mtTFA
110–179. The heavy atom positions were found
and the structure was phased using the program SOLVE
(32) and electron density was improved using CCP4 pro-
gram DM and RESOLVE (32). Much of the initial model
was built into a 1.35A ˚ SAD experimental map using the
program COOT (33) prior to the ﬁrst round of reﬁnement.
Refmac5 (CCP4 suite of programs) was used for maxi-
mum likelihood reﬁnement with cross-validation using
10% of the reﬂections reserved for the RFree calculation.
Water molecules were added over the process of several
reﬁnement cycles, and the structure was monitored for
correct geometry and stereochemistry using COOT with
a ﬁnal validation using PROCHECK (34). The ﬁnal pro-
tein model includes amino acids 111–177, with alternate
conformations for residues Tyr
120, Leu
140, Val
143, Lys
155,
Tyr
158, Met
173 and Ser
175, but amino acids 130–134 were
built as alanine due to poor electron density for this
region.
Root mean-squared deviation (RMSD) calculations
were made between h-mtTFA box B and several other
HMG protein structures that had been solved by either
NMR or X-ray crystallography, and the overall backbone
RMSD was calculated using the program Superpose (35).
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amino acid of the structures of HMGD [PDB ID 1qrv
(36)], SOX2 HMG box A (PDB ID 1gt0, Remenyi, A.,
Scholer, H.R., Wilmanns, M. unpublished), HMGB1
box A [PDB ID 1ckt (37)], LEF1 [PDB ID 2lef (38)]
and UBF5 [PDB ID 2hdz; Rong, H., Teng, M.K., and
Niu, L., unpublished data)] and the X-ray crystal structure
of h-mtTFA box B using the program COOT (33).
Structural alignments were generated with using the pro-
gram Chimera (39) and the structures were overlaid and
images generated using the program PYMOL (40).
Westernblot analysis
Deletion constructs of mtTFA were produced as pre-
viously described. A 1:1 Glutathione Sepharose 4B
(GE Health Sciences) suspension was made and equili-
brated in mtTFA buﬀer (50mM HEPES-Na, (pH 7.0),
150mM NaCl, 1mM EDTA and 1mM DTT). GST-
tagged mtTFA box B (mtTFA
110–179) was added and equi-
librated for 1 hour at 48C. Beads were spun down and
washed ﬁve times with mtTFA buﬀer prior to addition
of His6-mtTFA deletion constructs. Beads were then
washed with mtTFA buﬀer (50mM HEPES–Na (pH
7.5), 150mM NaCl, 1mM EDTA, 1mM DTT and 3%
BSA). Samples were boiled in 2  SDS–BME loading
dye and loaded on a 15% SDS–PAGE. The gel was trans-
ferred for 1h at 500mA onto a PVDF membrane
(Millipore) and blocked overnight in 3% BSA. Primary
His antibody (Novagen) 1:1000 was added with 3%
BSA for 1h and washed in TBST buﬀer. Secondary
HRP conjugated anti-mouse (GE Health Sciences)
1:100000 was added in TBST for 1h and washed in
TBST. A 1:1 of HRP substrate was added and imaged
by autoradiography. The membrane was stripped [25mM
glycine (pH 2) and 1% SDS] and reprobed with primary
anti-GST antibody (UCDHSC Tissue Culture Core) with
secondary antibody and imaged as described above.
RESULTS
HumanmtTFA exists as amonomer in theabsence of DNA
Although the function of h-mtTFA in mitochondrial tran-
scription initiation has been investigated in a variety of
species, the molecular mechanism of h-mtTFA assembly
of the mitochondrial transcription complex is still unclear.
In part, this is a result of disagreement about the stoichio-
metric state of h-mtTFA from the results of size-exclusion
chromatography, which suggested that h-mtTFA is a
dimer (23) and gradient and ultracentrifugation methods
(10) which showed that it is a monomer or potentially an
oligomer. To understand how h-mtTFA functions in pro-
moter binding, it is important to know the stoichiometric
state of h-mtTFA both in the presence and absence of
DNA. Therefore, structural and biochemical information
about HMG box structures was used to design a series of
h-mtTFA deletion constructs (Figure 1A). The proteins
were extensively puriﬁed so that they would be free
of DNA for biophysical studies [Figure 1A, by previously
established methods (36)]. Initially, we analyzed h-mtTFA
using size-exclusion chromatography and observed that
the full-length h-mtTFA, and all of the deletions of
h-mtTFA, had elution volumes that were consistent
with each protein having twice the expected molecular
weight (Figure 1B and Table 1). However, two well-
characterized HMG proteins that were known to be
monomers in the absence of DNA, HMGD and
HMGB1 box A (41,42), were also found to have elution
volumes that indicated a size twice that of what was
expected (Figure 1B and Table 1).
It is well known that asymmetric proteins have anoma-
lous elution proﬁles in size exclusion chromatography
(43). Therefore, we used analytical ultracentrifugation to
unequivocally determine the stoichiometry of h-mtTFA.
Three samples were subjected to sedimentation velocity
analysis over a 10-fold concentration range. The homoge-
neity of the sample was determined using continuous size
distribution analysis c(S) (Figure 1C and D). No evidence
of concentration dependent self-association was seen (data
not shown). The single and sharp peak in the c(S) analysis
indicates a single homogeneous species with a Svedberg
coeﬃcient of 1.80 (Figure 1D) and the frictional ratio
of 1.71 indicates that h-mtTFA exists in an asymmetric
conformation. The calculated molecular weight from this
analysis was 25958Da, which is within experimental error
( 10%) of the theoretical molecular weight for mono-
meric h-mtTFA of 24384Da. These results indicate that
in the absence of DNA h-mtTFA is present as a monomer
with an asymmetric shape in solution.
Human mtTFA assembles asahomodimer on the
mitochondrial promoter
The LSP and HSP binding sites protected from DNaseI
cleavage by h-mtTFA are approximately 30bp in length
(10,21). In contrast, the known HMGB binding site sizes
are considerably shorter, from 8bp for HMGD to 12bp
for LEF1 (36,38,44). To protect the observed length of
DNA, we hypothesized that h-mtTFA assembles on the
promoter DNA as either a dimer or an elongated mono-
mer, with each HMG box protecting half of the binding
site. The heterogeneous subunit assay introduced by Hope
and Struhl (45) was used to determine the stoichiometry of
h-mtTFA bound to the LSP promoter DNA (Figure 2).
Since h-mtTFA has the ability to bind to DNA both
sequence speciﬁcally and nonsequence speciﬁcally, we
chose a minimal length LSP binding site of 30bp that
maintained high aﬃnity h-mtTFA binding. h-mtTFA-
DNA complexes appeared as a single band (Figure 2,
lane 2). We also created a recombinant h-mtTFA fusion
protein with an N-terminal GST tag (GST-h-mtTFA),
and found that it also migrated as a single band but
with a lower mobility than that of the h-mtTFA-DNA
complexes (Figure 2, lane 3). When mixed together three
bands appeared (Figure 2, lane 4). The top and bottom
complexes could be attributed to DNA complexes with
homodimers of mtTFA and GST-mtTFA, and the new
band that migrates with an intermediate mobility between
these corresponds to the mtTFA/GST-mtTFA heterodi-
mer bound to DNA. The appearance of these bands is
consistent with the dimerization of mtTFA on the LSP
3156 Nucleic Acids Research, 2009, Vol. 37,No. 10promoter DNA, as other oligomers would have give rise
to additional bands in this experiment (Figure 2B).
Contributionof HMG boxes andthe C-terminal tail of
human mtTFA toDNA binding
In order to understand the contribution of each part of
h-mtTFA to DNA binding, we tested diﬀerent constructs
of h-mtTFA for their ability to bind to a 30bp LSP DNA
fragment. The C-terminal tail of h-mtTFA is important
for its site-speciﬁc binding to the mitochondrial promoters
and removal of this tail severally diminishes its ability
to activate transcription (21). Additionally, deletion of
the C-terminal tail reduced the DNA binding of h-
Figure 1. Human mtTFA is an asymmetric monomer in the absence of DNA. (A) Deletion constructs of h-mtTFA. The upper panel shows a
schematic diagram and the lower panel shows SDS–PAGE of h-mtTFA deletion constructs on a 15% polyacrylamide gel. (B) Size-exclusion
chromatography (Superdex 200; GE Healthcare) elution proﬁles of h-mtTFA and h-mtTFA deletion constructs, mtTFA
1–179, mtTFA
1–109,
mtTFA
1–79, mtTFA
80–204, mtTFA
110–204 and mtTFA
110–179 (top panel), and the single HMG domains, HMGB1 box A and HMGD (lower
panel) in 50mM HEPES–Na pH 7.0, 150mM NaCl, 1mM EDTA and 1mM DTT. The position of each size standard is indicated by arrows
above the top panel for amylase (158kDa), bovine serum albumin (67kDa), ovalbumin (43kDa), chymotrypsinogen A (25kDa) and RNase A
(14kDa). The void volume was at 45ml and is not shown. (C) Sedimentation velocity proﬁles for the raw data acquired at diﬀerent time points and
the residuals after ﬁttings had been performed using SEDFIT in 50mM HEPES–Na pH 7.0, 150mM NaCl, 1mM EDTA and 1mM DTT. (D)
Calculated sedimentation coeﬃcient distributions for the full-length h-mtTFA.
Table 1. Mass estimates from SEC and AUC for human mtTFA and
selected HMG boxes
Protein Theoretical
MW
Est. SEC MW Est. AUC
MW
h-mtTFA 24775 48977 25958
mtTFA
1–109 13229 22998 –
mtTFA
1–79 9763 19966 –
mtTFA
80–204 15281 28431 –
mtTFA
110–204 11743 24683 –
mtTFA
110–179 8753 16151 9833
HMGD 8353 17334 –
HMGB1 box A 8476 17957 –
Nucleic Acids Research, 2009,Vol.37, No. 10 3157mtTFA by three orders of magnitude (22). Based on these
ﬁndings, we fully expected that deletion of the C-terminal
tail would abolish the DNA binding of h-mtTFA.
However, in quantitative EMSA (Figure 3A and B), we
found that both h-mtTFA and the h-mtTFA
1–179 proteins
bound to the 30bp LSP with a Kdapp, for h-mtTFA of
5.4 0.6nM and for h-mtTFA
1–179 of 12.0 1.7nM. In
addition, competition EMSA using the LSP DNA or non-
speciﬁc DNA (NS DNA) of the same length and compo-
sition showed that the NS DNA competed similarly to the
LSP DNA for binding to mtTFA
1–179, but that the LSP
DNA competed better than NS DNA for binding to
mtTFA (Supplementary Figure S1). These results suggest
that the C-terminal tail of h-mtTFA is important for
the DNA binding speciﬁcity, but that it does not con-
tribute very much to the nonsequence-speciﬁc binding
of h-mtTFA.
The region of h-mtTFA (mtTFA
1–179) lacking the
C-terminal tail binds to DNA with near wild type aﬃnity
and is composed of tandem HMG boxes separated by
a linker region. In other HMGB proteins, with the possi-
ble exception of the upstream binding factor (UBF), all
HMG boxes are thought to independently bind to DNA.
To determine whether both of the HMG boxes of
h-mtTFA contribute to LSP binding, we used stoichio-
metric EMSA with roughly equal amounts of protein
and DNA at concentrations above the measured Kd. In
this experiment, both the full-length protein h-mtTFA and
HMG box A (h-mtTFA
1–79) bound to the LSP DNA,
whereas HMG box B (h-mtTFA
110–179) failed to bind
(Figure 3C). In case complexes of box B bound to
DNA were just not suﬃciently stable in electrophoresis,
we tested the ability of box B to compete with mtTFA for
DNA binding. We found that only at high concentrations
of added box B (4mM) was the complex of mtTFA–DNA
disrupted (Supplementary Figure S2). This result could be
due to weak binding of box B to either DNA or to other
regions of mtTFA. Therefore, h-mtTFA box A had the
ability to bind to DNA, but box B does not bind to duplex
DNA at reasonable concentrations. These results sup-
port the conclusion that h-mtTFA binds to the LSP
promoter DNA as a dimer, because the extent of protec-
tion is greater than that conferred by a single HMG-box,
and box B does not bind to duplex DNA independent
of box A.
Structure ofhuman mtTFA box B
Sequence alignments of the HMG domains of h-mtTFA
with other members of the HMG family suggest that
h-mtTFA box B may not be a canonical HMG domain
(Figure 4A). A variety of biophysical and structural
analyses have deﬁned the DNA binding modes of both
sequence-speciﬁc and nonspeciﬁc HMGB proteins
Figure 3. Contributions of regions of human mtTFA to DNA binding.
(A) Representation of typical EMSA used for binding curve analysis.
Lane 1 contains no protein: lanes 2 through 16 contains increasing
amounts of protein from 0.5 to 1000nM. (B) Binding curves for
mtTFA and mtTFA
1–179 with error bars. (C) EMSA using 3mM
30bp LSP DNA with increasing concentrations of h-mtTFA, box A
(mtTFA
1–79) or box B (mtTFA
110–179).
Figure 2. Human mtTFA binds to DNA as a dimer. (A) Heterogeneous
subunit assay with mtTFA and GST-mtTFA was performed using 2M
mtTFA (lane 2), 2M GST-mtTFA (lane 3), or both 1 M mtTFA and 1M
GST-mtTFA mixed together (lane 4), incubated with and loaded together
with 1M 30bp unlabeled LSP DNA fragment (lanes 1 to 4). Arrows
indicate the protein DNA complexes that form for mtTFA, GST-
mtTFA, or the mixture. The appearance of three bands in lane 4 indicates
that the binding species is a dimer of h-mtTFA, as illustrated in panel B.
(B) The red and grey circles represent GST-mtTFA and mtTFA with the
possibleproductsoftheirassemblyintodimers,trimersor tetramerforms.
3158 Nucleic Acids Research, 2009, Vol. 37,No. 10and has shown that these DNA binding modes are highly
similar (20). The HMG box binds to the ﬂattened, under-
wound and bent DNA minor groove using the large sur-
face of the concave face of the protein, bending the DNA
helix axis away from the site of contact (36,38,46,47). The
binding interface includes electrostatic interactions,
hydrogen bonds, and van der Waals contacts, as well as
important partially intercalating nonpolar residues pres-
ent in either helix a1o ra2 of the HMG box. The inter-
calating residue in helix a1 (Figure 4A, ﬁrst arrow) is
found in all of the sequence-speciﬁc HMGB proteins. In
the nonsequence-speciﬁc HMGB proteins, there is also an
additional intercalating residue at the beginning of helix
a2 (Figure 4A, second arrow), and every known DNA
binding HMG box has at least one nonpolar residue capa-
ble of intercalation at one or the other of these sites.
Substitution of these intercalating residues with alanine
or nonpolar amino acid residues signiﬁcantly decreases
the ability of the HMG domain to bind DNA (19,31).
The presence of an asparagine residue at position 121 in
h-mtTFA box B (Figure 4A, ﬁrst arrow, blue box) sug-
gests that this residue in box B would be unable to inter-
calate DNA (31). In addition, the other region that is
known to make DNA contacts is completely absent
from the N-terminus of helix a2 (Figure 4A, second
arrow, blue box).
In order to determine whether the deﬁciency of
h-mtTFA box B in DNA binding may be due to its unusual
noncanonical form, we determined the structure using
X-ray crystallography. Box B of h-mtTFA (amino acids
110–179) was crystallized using standard approaches, and
the structure was solved using single-wavelength anoma-
lous diﬀraction (SAD) methods (Table 2). The ﬁnal
reﬁned structure is reported to 1.35A ˚ resolution (PDB
ID 3fgh). Box B of h-mtTFA maintains the global fold
of three helices stabilized in an L-shape conﬁguration,
which is stabilized by two hydrophobic cores similar to
the other HMG proteins (Figures 4B and 5A). The hydro-
phobic core between helix a1 and helix a2 contains two
amino acids (Tyr
120 and Tyr
158) that have multiple con-
formations suggesting a highly dynamic core that has not
been seen in the nonsequence-speciﬁc HMG structures
(Figure 4C), but is reminiscent of the less rigid hydropho-
bic cores seen in the sequence-speciﬁc transcription factors,
Sox5 and SRY in the absence of DNA (46,48). The
presence of Asn
121 in helix a1 and the shortened length of
helix a2 conﬁrm that the intercalation residues in helix a1
and a2 that were predicted to be missing in this domain
are in fact not there, and not compensated by other resi-
dues or structural changes. Interestingly, the yeast mito-
chondrial nucleoid protein Abf2 has similar anomalous
features in its box B as human mtTFA (Figure 4A).
Figure 4. X-ray crystal structure of human mtTFA box B. (A) Sequence alignments of box A and box B of h-mtTFA, box A and box B of HMG1,
HMGD, NHP6A and Abf2. Global structure of an HMG protein is shown by diagram of helices a1, a3 and a3at the bottom. Green boxes are
residues that are conserved among all of the proteins. The arrows point to residues that are known to be involved in intercalating the DNA. (B)
Ribbon diagram drawing of the backbone of box B showing the global fold of three helices stabilized into an L-shape conﬁguration. The image was
generated with PYMOL (40). (C) Hydrophobic core of box B with amino acids Tyr
120, Tyr
123, Trp
147 and Tyr
158 shown.
Nucleic Acids Research, 2009,Vol.37, No. 10 3159Therefore, this analysis helped to explain why
h-mtTFA box B fails to bind the LSP promoter DNA,
and suggests that box B most likely evolved to play another
role in h-mtTFA.
To explore the possible roles of h-mtTFA box B in the
function of h-mtTFA, we compared the box B structure to
many HMG box structures that have been solved by crys-
tallography and NMR. Table 3 lists the RMSDs of a rep-
resentative group of HMG domains aligned with box B of
h-mtTFA, and shows that there is a wide range of overall
RMSD values between these structures. The structural
alignment (Figure 5A) and per residue RMSD analysis
(Figure 5B) illustrated that the N-terminal strand and
helix a3 of the HMG boxes are the most conserved fea-
tures. There were large RMSDs at the C-terminal end of
helix a1, the linker connecting helix a1 and helix a2
between amino acids 131 and 141, and the N-terminal
part of helix a2 (Figure 5B). The comparison of
h-mtTFA box B to nonspeciﬁc HMG protein HMG
boxes, such as HMGB1 box A bound to DNA (37) and
HMGD bound to DNA (36), showed that helix a1i s
shorter and there is a shorter linker connecting helix a1
and helix a2. This linker region is also signiﬁcantly shorter
than the linker in other HMG boxes, except for
HMG box 5 of UBF, which was the most similar
to box B of h-mtTFA in this region. Interestingly, this
region is particularly important for duplex DNA binding
and bending. As seen in an overlay diagram of box B with
the HMGD-DNA complex (Figure 5C), this region of
h-mtTFA box B does not approach the DNA as closely
as HMGD does and it lacks the expected DNA intercalat-
ing residues. The presence of the polar amino acid Asn
121
in the intercalating position normally occupied by a
nonpolar residue in other HMG boxes suggests
box B lacks the ability to intercalate the minor groove
(Figure 5C).
Despite the diﬀerences in the tertiary structural features
of box B of h-mtTFA compared to other HMG boxes, the
surface electrostatic features of the HMG boxes are simi-
lar. The electrostatic surface map of h-mtTFA box B was
compared to HMGB1 box A, HMGD, and UBF box 5,
and showed clearly that the concave surface area that is
typically involved in DNA binding was positively charged
in all of the HMG boxes (Figure 5D). The presence of
such a basic DNA binding surface most certainly suggests
that box B may bind to DNA, although we suggest that it
may not be in the canonical mode of binding seen for
other HMG boxes.
Interactions of human mtTFA box Bwithother regions
of mtTFA
Although h-mtTFA is a monomer, the multiple domains
within the protein may be important in the internal struc-
turing of the protein. Kaufman et al. (23) previously sug-
gested that box B played a role in dimerization, and this
occurred through a coiled-coil mechanism. Although we
showed that the full-length h-mtTFA is a monomer in
solution, box B was seen to interact through a homomeric
anti-parallel helical interaction involving helix a3 of sym-
metry related molecules in the crystal (Supplementary
Figure S3). Therefore, we tested the ability of box B
alone to dimerize using analytical ultracentrifugation
and found that it also was present as a monomer in solu-
tion (Table 1 and Supplementary Figure S4). We next
tried to detect interactions between box B and itself as
well as a number of the h-mtTFA deletion proteins
using pull-down assays (Figure 6) and found that box B
interacted with box A and the linker region between box A
and box B (Figure 6, top panel, lane 3). We truncated the
linker region and conﬁrmed that box B interacts with a
region of amino acids between 80 and 95 (Figure 6,
bottom panel, lane 3). Box B failed to interact with itself
(Figure 6, middle panel, lane 6) but did show a weak inter-
action with the h-mtTFA
80–204 protein (Figure 6, top
panel, lane 9). Therefore, box B binds to box A and part
of the linker included between 80-95 and likely is involved
in some internal structuring of the protein. Although these
experiments alone do not rule out that box B may play a
role in DNA mediated dimerization they conﬁrm
that box B alone does not dimerize.
DISCUSSION
This analysis of the structural features and DNA binding
properties of the HMG boxes of h-mtTFA provides new
insights into the ﬁrst steps of mitochondrial transcription
complex assembly. We ﬁrst showed that h-mtTFA is a
monomer in solution and assembles as a dimer on a
single LSP binding site (Figures 1 and 2). The C-terminal
tail of h-mtTFA was not needed for nonsequence-speciﬁc
DNA binding (Figure 3A and B). Furthermore, the
canonical HMG box h-mtTFA box A bound indepen-
dently to the LSP DNA (Figure 3C), and as such appears
Table 2. Data collection and reﬁnement statistics
Characteristics mtTFA
110–179
Wavelength (A ˚ ) 0.98
Space group C2221
Unit-cell parameters 30.28 99.35 51.90
a, b, c (A ˚ )
Resolution (A ˚ ) 28.96–1.35
Total number of reﬂ. 119994
Total of unique reﬂ. 17556
Multiplicity 6.83 (5.17)
Rmerge
a 4.9 (22.1)
I/s (I) 19.8 (5.7)
Overall completeness (%) 99.2
Resolution reﬁnement (A ˚ ) 28–1.35
Reﬂections (working/test) 15765/1771
Rcryst/Rfree
b 18.8/21.4
Nonhydrogen atoms 674
Water molecules 51
Bonds (A ˚ ) 0.012
Angles (8) 1.524
Mean B factor (A ˚ ) Protein 20.38
Ramachadran analysis: residues in
the most-favored/allowed (%)
57/100
aRmerge=
P
h
P
i | Ihi   < Ih> |/
P
h
P
I|hi, were |hi is the i-th observation
of the reﬂection h, while < Ih> is the mean intensity of reﬂection h.
bRfactor=
P
kFo|  k FCk/|Fo|. Rfree was calculated with a set of
randomly selected reﬂections (10%).
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contrast, h-mtTFA box B did not bind to the LSP DNA
by itself (Figure 3C), and as a variant HMG box
(Figures 4 and 5) it has features that suggest why it may
not be expected to bind to DNA in the canonical fashion.
In addition, box B alone did not dimerize (Supplementary
Figure S1), but it did interact with other regions of
mtTFA (Figure 6). This suggests that box B may be
involved in stabilizing interactions with h-mtTFA within
the free protein and in the homodimeric protein DNA
complex or potentially acting at a later step in transcrip-
tional activation.
Implications of h-mtTFA stoichiometry inLSP recognition
In the absence of DNA, h-mtTFA is present as a mono-
mer with a highly asymmetric shape (Figure 1). We attri-
bute the anomalous elution proﬁles of a dimer seen in the
studies by our lab and others using size-exclusion chroma-
tography to the asymmetric shape of the protein (23).
Figure 5. Comparison of human mtTFA box B with other HMGB proteins. (A) Structural superposition of box B of h-mtTFA (3fgh; red) overlaid
with HMGD (1qrv; yellow), UBF box 5 (2hdz; green), LEF1 (2lef; purple), HMGB1 box A (1ckt; cyan) and Sox2 (1gt0; black). (B) RMSD
comparisons per amino acid were calculated using the program COOT, and were plotted against the amino acid sequence of h-mtTFA box B. The
same color scheme was used as in (A). The solid line indicates the mean RMSD for the HMG boxes that were aligned. (C) Superposition of box B of
h-mtTFA (red) on HMGD (yellow) in the HMGD–DNA complex and showing the shortened loop between helix a1 and a2 and the decreased size of
helix a1. (D) Electrostatic surface potential plot of box B (mtTFA
110–179), HMGB1 box A, HMGD, and UBF box 5 generated with PYMOL.
Regions of positive potential are colored blue, and regions of negative potential are colored red.
Nucleic Acids Research, 2009,Vol.37, No. 10 3161More diﬃcult to explain is an additional peak that was
seen in the presence of high salt (500mM NaCl) in the
size-exclusion experiments by Kaufman et al. (23,43).
This peak was interpreted to be a monomer, although
alternate explanations are possible, as the deoxycholate
and high salt present in the chromatography buﬀer
could have aﬀected how h-mtTFA eluted due to potential
micelle formation.
It has been widely thought that h-mtTFA minimally
forms higher ordered structures on the mitochondrial pro-
moters. Support for this model has come from the obser-
vation of higher ordered structures of dimers, trimers and
tetramers with xl-mtTFA (24), and h-mtTFA has been
shown to bind cooperatively as a dimer with nanomolar
aﬃnity (23). However, h-mtTFA has also been shown to
function as a monomer when binding to Holliday
Junctions (49). Here we clearly showed that in the absence
of DNA, h-mtTFA exists as a monomer (Figure 1), and
that it assembles as a dimer on a short segment of the
mitochondrial promoter (Figure 2). This is a unique fea-
ture of mtTFA, as other HMG-box proteins bind DNA as
monomers or in the case of UBF are obligate dimers
(50,51). Thus, we conclude that a crucial step in setting
up the preinitiation complex at the mitochondrial pro-
moter is assembly and dimerization of h-mtTFA on the
DNA.
Another step of transcription complex assembly
involves the recruitment of h-mtTFB proteins and the
mitochondrial polymerase. The LSP is an asymmetric
sequence and initiation only occurs at one site that is
located at a speciﬁc distance from the h-mtTFA binding
site (21,52). Therefore, the fact that h-mtTFA is a mono-
mer suggests that the sequence and structure of the DNA
may also play a role in setting up an asymmetric complex.
It was previously shown that the h-mtTFA C-terminal tail
was required for footprinting the LSP and for transcrip-
tional activity (21), as well as for recruitment of h-mtTFB1
and h-mtTFB2 (15). It is certainly possible that mtTFA
and mtTFB can assemble together on the DNA, although
this has not been observed potentially due to the dynamics
of the complex. Interestingly, the ability of h-mtTFA to
bind DNA was only slightly diminished by removal of the
C-terminal tail (Figure 3A and B, Supplementary
Figure S1), which suggests that it aids in the formation
of the correct speciﬁc complex on the LSP. This could be
because the tail contributes additional contacts that pro-
vide for the site-speciﬁcity for the mitochondrial pro-
moter. Surprisingly, Kang and coworkers found that a
similar C-terminal truncation in h-mtTFA decreased the
binding aﬃnity in surface plasmon resonance experiments
by greater than 1000 fold, but in DNA unwinding in
supercoiling assays this diﬀerence was only 8-fold (22).
The diﬀerence in aﬃnity that we measured for the deletion
of the C-terminal tail is 2.4-fold. The discrepancies
between these numbers could be due to the diﬀerent pro-
tein preparations and the approaches that were used.
Figure 6. Human mtTFA box B interacts with other regions of
mtTFA. An N-terminal GST fusion with box B (mtTFA
110–179) was
tested for its ability to interact with the various deletion constructs of
h-mtTFA (mtTFA
1-109, mtTFA
1–79, mtTFA
1–80–204, mtTFA
110–204,
mtTFA
110–179, mtTFA
80–179, mtTFA
1–95 and mtTFA
96–179)i n5 0 m M
HEPES–Na pH 7.0, 150mM NaCl, 1mM EDTA and 1mM DTT.
The reactions were electrophoresed on a 15% SDS–PAGE gel and
transferred to nitrocellulose membrane (Millipore) and probed with
anti-His and anti-GST antibodies, respectively.
Table 3. Structural comparison of selected HMG boxes
PDB Protein RMSD (A ˚ ) Method
2HDZ UBF box 5 1.35 X-Ray
1J3C HMGB2 box B 1.40 NMR
1QRV HMGD/DNA 1.49 X-Ray
2LEF LEF1/DNA 1.50 NMR
1CKT HMGB1 box A/DNA 1.87 X-Ray
1J3X HMGB2 box A 2.04 NMR
1HMF HMGB1 box B 2.23 NMR
2YUL SOX17 2.28 NMR
2YQI HMGB3 box B 2.33 NMR
2EZQ HMGB3 box A 2.36 NMR
1V63 UBF box 6 2.38 NMR
1AAB HMGB1 box A 2.53 NMR
1GTO SOX2/DNA 2.93 X-Ray
1V64 UBF box 3 3.10 NMR
1K99 UBF box 1 3.13 NMR
1HRY SRY/DNA 3.73 NMR
1WGF UBF box 4 5.42 NMR
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HMG boxes are found in proteins that are involved in
numerous functions from signaling in inﬂammation to
transcriptional regulation and the maintenance of DNA
architectures (18,19,53). Although, it is thought that most
HMG boxes bind and bend DNA in a similar fashion,
many functions of HMG boxes are still not understood
at the molecular level. h-mtTFA box B did not bind
to DNA by itself (Figure 3C) and its sequence diﬀers
in regions of the protein that are known to be crucial
for DNA binding in other HMGB proteins (Figures 4A
and 5). This anomalous property of box B is most likely
due to the unusual presence of a polar residue in the posi-
tion typically occupied by a residue capable of intercalat-
ing into the minor groove of DNA (20,31). In addition,
the lack of any putative intercalating residues in the region
of the short helix a1 and the linker between helices a1 and
a2 further explains it inability to bind DNA. These
features suggest that box B of h-mtTFA would not bind
DNA in the typical fashion seen for other HMG proteins.
That is not to say that box B would fail to bind to either
duplex or single stranded DNA under the correct condi-
tions. For example, Ohno et al. (49) observed that both of
the HMG boxes were needed for binding of h-mtTFA to
Holliday Junction DNA. Therefore, depending on the
context, box B may play a role in binding of certain types
of DNA that may be generated in the course of promoter
opening and stabilization of the transcription complex.
Box B of h-mtTFA interacts with other domains
of h-mtTFA (Figure 6). Box B closely resembles
UBF box 5, which is one of the HMG boxes in the
multi-HMG-box organelle speciﬁc transcription factor
UBF (Figure 5). UBF in mammals is involved in tran-
scription of ribosomal DNA. It has six HMG boxes of
which the ﬁrst two are involved directly in DNA binding,
but the function of the remaining HMG boxes is unknown
(50,51,54,55). However, Moss and coworkers have pro-
posed that HMG boxes 3-6 may be involved in formation
of the ribosomal enhancesome through protein–protein
interactions (50). HMGB proteins are known to interact
with other proteins; for example HMGB1 interacts with
P53, steroid receptors, and many others (18). Our results
suggest that box B in h-mtTFA may be involved in inter-
actions with other regions of h-mtTFA, including a por-
tion of box A, a short putative helical segment that
follows box A contained in the linker region (Figure 6),
and potentially the C-terminal tail. The surface represen-
tation of box B also shows a deep acidic cavity in the core
region between helix a1 and helix a3 that is not present in
these other proteins (Figure 5D), and may be the site of
additional protein–protein interactions, such as those that
may occur with p53 (56). Therefore, we conclude
that box B of h-mtTFA likely participates in an alternate
mode of DNA binding and/or protein–protein inter-
actions that occur during assembly of the transcription
initiation complex.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Christopher Malarkey for critical reading of the
article. We are very grateful to Gerald Shadel for provid-
ing the initial h-mtTFA plasmid construct and advice. We
thank the staﬀ at beamline 4.2.2 at the Advanced Light
Source, Lawrence Berkeley National Lab, Brooke Hirsch
at the UCD Biophysics Core Facility for collection of the
mtTFA
110–179 sedimentation velocity data, and Dominic
Esposito at NCI, who generously donated the pDEST15
and pDEST 527 for the Gateway expression system.
FUNDING
The UCD Biomolecular X-ray Crystallography Center by
HHMI (in part); the University of Colorado Cancer
Center; National Institutes of Health; UMDF (05-101,
#68859 to M.E.A.C). Funding for open access charge:
MDA (#68859) and institutional funds.
Conﬂict of interest statement. None declared.
REFERENCES
1. Clayton,D.A. (1991) Replication and transcription of vertebrate
mitochondrial DNA. Annu. Rev. Cell Biol., 7, 453–478.
2. Anderson,S., Bankier,A.T., Barrell,B.G., de Bruijn,M.H.,
Coulson,A.R., Drouin,J., Eperon,I.C., Nierlich,D.P., Roe,B.A.,
Sanger,F. et al. (1981) Sequence and organization of the human
mitochondrial genome. Nature, 290, 457–465.
3. Taylor,R.W. and Turnbull,D.M. (2005) Mitochondrial DNA
mutations in human disease. Nat. Rev. Genet., 6, 389–402.
4. Bonawitz,N.D., Clayton,D.A. and Shadel,G.S. (2006) Initiation
and beyond: multiple functions of the human mitochondrial tran-
scription machinery. Mol. Cell, 24, 813–825.
5. Greaves,L.C. and Taylor,R.W. (2006) Mitochondrial DNA
mutations in human disease. IUBMB Life, 58, 143–151.
6. Wallace,D.C. (2005) A mitochondrial paradigm of metabolic and
degenerative diseases, aging, and cancer: a dawn for evolutionary
medicine. Annu. Rev. Genet., 39, 359–407.
7. Shadel,G.S. and Clayton,D.A. (1993) Mitochondrial transcription
initiation. Variation and conservation. J. Biol. Chem., 268,
16083–16086.
8. Shadel,G.S. (2008) Expression and maintenance of mitochondrial
DNA: new insights into human disease pathology. Am. J. Pathol.,
172, 1445–1456.
9. Shoubridge,E.A. (2002) The ABCs of mitochondrial transcription.
Nat. Genet., 31, 227–228.
10. Fisher,R.P. and Clayton,D.A. (1988) Puriﬁcation and
characterization of human mitochondrial transcription factor 1.
Mol. Cell Biol., 8, 3496–3509.
11. Fisher,R.P., Lisowsky,T., Parisi,M.A. and Clayton,D.A. (1992)
DNA wrapping and bending by a mitochondrial high mobility
group-like transcriptional activator protein. J. Biol. Chem., 267,
3358–3367.
12. Falkenberg,M., Gaspari,M., Rantanen,A., Trifunovic,A.,
Larsson,N.G. and Gustafsson,C.M. (2002) Mitochondrial
transcription factors B1 and B2 activate transcription of human
mtDNA. Nat. Genet., 31, 289–294.
13. McCulloch,V., Seidel-Rogol,B.L. and Shadel,G.S. (2002) A human
mitochondrial transcription factor is related to RNA adenine
methyltransferases and binds S-adenosylmethionine. Mol. Cell Biol.,
22, 1116–1125.
14. Seidel-Rogol,B.L., McCulloch,V. and Shadel,G.S. (2003) Human
mitochondrial transcription factor B1 methylates ribosomal RNA at
a conserved stem-loop. Nat. Genet., 33, 23–24.
15. McCulloch,V. and Shadel,G.S. (2003) Human mitochondrial
transcription factor B1 interacts with the C-terminal activation
region of h-mtTFA and stimulates transcription independently of its
RNA methyltransferase activity. Mol. Cell Biol., 23, 5816–5824.
Nucleic Acids Research, 2009,Vol.37, No. 10 316316. Cotney,J. and Shadel,G.S. (2006) Evidence for an early gene
duplication event in the evolution of the mitochondrial transcription
factor B family and maintenance of rRNA methyltransferase
activity in human mtTFB1 and mtTFB2. J. Mol. Evol., 63, 707–717.
17. Cotney,J., Wang,Z. and Shadel,G.S. (2007) Relative abundance of
the human mitochondrial transcription system and distinct roles for
h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene
expression. Nucleic Acids Res., 35, 4042–4054.
18. Stros,M., Launholt,D. and Grasser,K.D. (2007) The HMG-box: a
versatile protein domain occurring in a wide variety of
DNA-binding proteins. Cell Mol. Life Sci., 64, 2590–2606.
19. Thomas,J.O. and Travers,A.A. (2001) HMG1 and 2, and related
‘architectural’ DNA-binding proteins. Trends Biochem. Sci., 26,
167–174.
20. Murphy, F.V.t. and Churchill,M.E. (2000) Nonsequence-speciﬁc
DNA recognition: a structural perspective. Structure, 8, R83–R89.
21. Dairaghi,D.J., Shadel,G.S. and Clayton,D.A. (1995) Addition of
a 29 residue carboxyl-terminal tail converts a simple HMG box-
containing protein into a transcriptional activator. J. Mol. Biol.,
249, 11–28.
22. Ohgaki,K., Kanki,T., Fukuoh,A., Kurisaki,H., Aoki,Y.,
Ikeuchi,M., Kim,S.H., Hamasaki,N. and Kang,D. (2007) The
C-terminal tail of mitochondrial transcription factor a markedly
strengthens its general binding to DNA. J. Biochem., 141, 201–211.
23. Kaufman,B.A., Durisic,N., Mativetsky,J.M., Costantino,S.,
Hancock,M.A., Grutter,P. and Shoubridge,E.A. (2007) The
mitochondrial transcription factor TFAM coordinates the
assembly of multiple DNA molecules into nucleoid-like structures.
Mol. Biol. Cell, 18, 3225–3236.
24. Antoshechkin,I., Bogenhagen,D.F. and Mastrangelo,I.A. (1997)
The HMG-box mitochondrial transcription factor xl-mtTFA
binds DNA as a tetramer to activate bidirectional transcription.
EMBO J., 16, 3198–3206.
25. Kanki,T., Ohgaki,K., Gaspari,M., Gustafsson,C.M., Fukuoh,A.,
Sasaki,N., Hamasaki,N. and Kang,D. (2004) Architectural role of
mitochondrial transcription factor A in maintenance of human
mitochondrial DNA. Mol. Cell Biol., 24, 9823–9834.
26. Ekstrand,M.I., Falkenberg,M., Rantanen,A., Park,C.B.,
Gaspari,M., Hultenby,K., Rustin,P., Gustafsson,C.M. and
Larsson,N.G. (2004) Mitochondrial transcription factor A regulates
mtDNA copy number in mammals. Hum. Mol. Genet., 13, 935–944.
27. Ghivizzani,S.C., Madsen,C.S. and Hauswirth,W.W. (1993) In
organello footprinting. Analysis of protein binding at regulatory
regions in bovine mitochondrial DNA. J. Biol. Chem., 268,
8675–8682.
28. Bogenhagen,D.F., Wang,Y., Shen,E.L. and Kobayashi,R. (2003)
Protein components of mitochondrial DNA nucleoids in higher
eukaryotes. Mol. Cell Proteomics, 2, 1205–1216.
29. Lee,K.M. and Hayes,J.J. (1997) The N-terminal tail of histone H2A
binds to two distinct sites within the nucleosome core. Proc. Natl
Acad. Sci. USA, 94, 8959–8964.
30. Schuck,P., Perugini,M.A., Gonzales,N.R., Howlett,G.J. and
Schubert,D. (2002) Size-distribution analysis of proteins by
analytical ultracentrifugation: strategies and application to model
systems. Biophys. J., 82, 1096–1111.
31. Klass,J., Murphy,F.V.t., Fouts,S., Serenil,M., Changela,A., Siple,J.
and Churchill,M.E. (2003) The role of intercalating residues in
chromosomal high-mobility-group protein DNA binding, bending
and speciﬁcity. Nucleic Acids Res., 31, 2852–2864.
32. Terwilliger,T.C. and Berendzen,J. (1999) Automated MAD and
MIR structure solution. Acta Crystallogr. D Biol. Crystallogr., 55
(Pt 4), 849–861.
33. Emsley,P. and Cowtan,K. (2004) Coot: model-building tools for
molecular graphics. Acta Crystallogr. D Biol. Crystallogr., 60,
2126–2132.
34. Laskowski,R.A., Moss,D.S. and Thornton,J.M. (1993) Main-chain
bond lengths and bond angles in protein structures. J. Mol. Biol.,
231, 1049–1067.
35. Maiti,R., Van Domselaar,G.H., Zhang,H. and Wishart,D.S. (2004)
SuperPose: a simple server for sophisticated structural superposi-
tion. Nucleic Acids Res., 32, W590–W594.
36. Murphy,F.V. IV, Sweet,R.M. and Churchill,M.E. (1999) The
structure of a chromosomal high mobility group protein-DNA
complex reveals sequence-neutral mechanisms important for non-
sequence-speciﬁc DNA recognition. EMBO J., 18, 6610–6618.
37. Ohndorf,U.M., Rould,M.A., He,Q., Pabo,C.O. and Lippard,S.J.
(1999) Basis for recognition of cisplatin-modiﬁed DNA by high-
mobility-group proteins. Nature, 399, 708–712.
38. Love,J.J., Li,X., Case,D.A., Giese,K., Grosschedl,R. and
Wright,P.E. (1995) Structural basis for DNA bending by the
architectural transcription factor LEF-1. Nature, 376, 791–795.
39. Pettersen,E.F., Goddard,T.D., Huang,C.C., Couch,G.S.,
Greenblatt,D.M., Meng,E.C. and Ferrin,T.E. (2004) UCSF
Chimera–a visualization system for exploratory research and
analysis. J. Comput. Chem., 25, 1605–1612.
40. DeLano, W.L. (2002) The PyMOL Molecular Graphics System
(2002) on World Wide Web http://www.pymol.org
41. Jones,D.N.M., Searles,A., Shaw,G.L., Churchill,M.E.A., Ner,S.S.,
Keeler,J., Travers,A.A. and Neuhaus,D. (1994) The solution
structure and dynamics of the DNA-binding domain of HMG-D
from Drosophila melanogaster. Structure, 2, 609–627.
42. Hardman,C.H., Broadhurst,R.W., Raine,A.R., Grasser,K.D.,
Thomas,J.O. and Laue,E.D. (1995) Structure of the A-domain of
HMG1 and its interaction with DNA as studied by heteronuclear
three- and four-dimensional NMR spectroscopy. Biochemistry, 34,
16596–16607.
43. Tarvers,R.C. and Church,F.C. (1985) Use of high-performance size-
exclusion chromatography to measure protein molecular weight and
hydrodynamic radius. An investigation of the properties of the TSK
3000 SW column. Int. J. Pept. Protein Res., 26, 539–549.
44. Giese,K., Pagel,J. and Grosschedl,R. (1997) Functional analysis of
DNA bending and unwinding by the high mobility group domain of
LEF-1. Proc. Natl Acad. Sci. USA, 94, 12845–12850.
45. Hope,I.A. and Struhl,K. (1987) GCN4, a eukaryotic transcriptional
activator protein, binds as a dimer to target DNA. EMBO J., 6,
2781–2784.
46. Werner,M.H., Huth,J.R., Gronenborn,A.M. and Clore,G.M. (1995)
Molecular basis of human 46X,Y sex reversal revealed from the
three-dimensional solution structure of the human SRY-DNA
complex. Cell, 81, 705–714.
47. Masse,J.E., Wong,B., Yen,Y.M., Allain,F.H., Johnson,R.C. and
Feigon,J. (2002) The S. cerevisiae architectural HMGB protein
NHP6A complexed with DNA: DNA and protein conformational
changes upon binding. J. Mol. Biol., 323, 263–284.
48. Cary,P.D., Read,C.M., Davis,B., Driscoll,P.C. and
Crane-Robinson,C. (2001) Solution structure and backbone
dynamics of the DNA-binding domain of mouse Sox-5. Protein Sci.,
10, 83–98.
49. Ohno,T., Umeda,S., Hamasaki,N. and Kang,D. (2000) Binding of
human mitochondrial transcription factor A, an HMG box protein,
to a four-way DNA junction. Biochem. Biophys. Res. Commun.,
271, 492–498.
50. Stefanovsky,V.Y., Pelletier,G., Bazett-Jones,D.P., Crane-
Robinson,C. and Moss,T. (2001) DNA looping in the RNA poly-
merase I enhancesome is the result of non-cooperative in-phase
bending by two UBF molecules. Nucleic Acids Res., 29, 3241–3247.
51. Bazett-Jones,D.P., Leblanc,B., Herfort,M. and Moss,T. (1994)
Short-range DNA looping by the Xenopus HMG-box transcription
factor, xUBF. Science, 264, 1134–1137.
52. Gaspari,M., Falkenberg,M., Larsson,N.G. and Gustafsson,C.M.
(2004) The mitochondrial RNA polymerase contributes critically to
promoter speciﬁcity in mammalian cells. EMBO J., 23, 4606–4614.
53. Bianchi,M.E. and Manfredi,A. (2004) Chromatin and cell death.
Biochim. Biophys. Acta, 1677, 181–186.
54. Stefanovsky,V.Y. and Moss,T. (2008) The splice variants of UBF
diﬀerentially regulate RNA polymerase I transcription elongation in
response to ERK phosphorylation. Nucleic Acids Res., 36,
5093–5101.
55. Stefanovsky,V.Y., Bazett-Jones,D.P., Pelletier,G. and Moss,T.
(1996) The DNA supercoiling architecture induced by the tran-
scription factor xUBF requires three of its ﬁve HMG-boxes. Nucleic
Acids Res., 24, 3208–3215.
56. Yoshida,Y., Izumi,H., Torigoe,T., Ishiguchi,H., Itoh,H., Kang,D.
and Kohno,K. (2003) P53 physically interacts with mitochondrial
transcription factor A and diﬀerentially regulates binding to
damaged DNA. Cancer Res., 63, 3729–3734.
3164 Nucleic Acids Research, 2009, Vol. 37,No. 10